The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis

Clinical trial NCT06606275 · COMPLETED

Trial details

NCT number: NCT06606275
Sponsor: Abu Dhabi Health Services Company
Status: COMPLETED
Study type: OBSERVATIONAL

End-Stage Kidney Disease (ESKD)Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)

Start date: 2024-01-01
Primary completion: 2024-11-04
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.